Flavio Ribichini

Showing 1-18 of 18 articles

Coronary interventions

Pressure-bounded coronary flow reserve to assess the extent of microvascular dysfunction in patients with ST-elevation acute myocardial infarction.

Scarsini R, De Maria G, Shanmuganathan M, Kotronias RA, Terentes-Printzios D, Langrish J, Lucking A, Ribichini F, Choudhury R, Kharbanda R, Ferreira V, Channon KM, Banning A, Borlotti A, Dawkins S

December 23, 2019 | 10.4244/EIJ-D-19-00674

Coronary interventions

Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trial

Toth G, De Bruyne B, Kala P, Ribichini F, Casselman F, Ramos R, Piroth Z, Fournier S, Piccoli A, Van Mieghem C, Penicka M, Mates M, Nemec P, Van Praet F, Stockman B, Degriek I, Barbato E

December 6, 2019 | 10.4244/EIJ-D-19-00463

Interventions for valvular disease

Sapien 3 Ultra balloon-expandable transcatheter aortic valve: in-hospital and 30-day results from the multicentre S3U registry

Saia F, Gandolfo C, Palmerini T, Berti S, Doshi SN, Laine M, Marcelli C, Piva T, Ribichini F, De Benedictis M, Cardaioli F, Cannata S, Tarantini G

November 26, 2019 | 10.4244/EIJ-D-19-00541

NVT ALLEGRA transcatheter heart valve for valve-in-valve procedures in failing surgical aortic bioprostheses: let us wait and see

Pighi M, Lunardi M, Ribichini F

October 4, 2019 | 10.4244/EIJV15I9A137

Coronary interventions

Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting. The GRAFFITI trial

Toth G, De Bruyne B, Kala P, Ribichini F, Casselman F, Ramos R, Piroth Z, Fournier S, Piccoli A, Van Mieghem C, Penicka M, Mates M, Nemec P, Van Praet F, Stockman B, Degriek I, Barbato E

July 2, 2019 | 10.4244/EIJ-D-19-00463

The promise of vascular reparative therapy in standby mode. How long before a final decision? Complete vessel wall regeneration and vascular scaffold resorption after left anterior descending reconstructions

Ribichini F, Pesarini G

July 20, 2018 | 10.4244/EIJV14I4A65

Physiologic evaluation of coronary lesions using instantaneous wave-free ratio (iFR) in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation

Scarsini R, Pesarini G, Zivelonghi C, Piccoli A, Ferrero V, Lunardi M, Gottin L, Zanetti C, Faggian G, Ribichini F

January 19, 2018 | 10.4244/EIJ-D-17-00542

Which is the best antiaggregant or anticoagulant therapy after TAVI? A propensity-matched analysis from the ITER registry. The management of DAPT after TAVI

D’ascenzo F, Benedetto U, Bianco M, Conrotto F, Moretti C, D’Onofrio A, Agrifoglio M, Colombo A, Ribichini F, Tarantini G, D’Amico M, Salizzoni S, Rinaldi M

December 8, 2017 | 10.4244/EIJ-D-17-00198

Coronary interventions

One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS)

Testa L, De Carlo M, Petrolini A, Rapetto C, Varbella F, Cortese B, Gabrielli G, Geraci S, Loi B, Boccuzzi G, Tarantini G, Fischetti D, Calabria P, Tomai F, Ribichini F, Tamburino C, Indolfi C, Bartorelli A, Petronio A, Bedogni F

July 20, 2017 | 10.4244/EIJ-D-17-00246

European expert consensus on rotational atherectomy

Barbato E, Carrié D, Dardas P, Fajadet J, Gaul G, Haude M, Khashaba A, Koch K, Meyer-Gessner M, Palazuelos J, Reczuch K, Ribichini F, Sharma SK, Sipotz J, Sjögren I, Suetsch G, Szabo G, Valdés Chávarri M, Vaquerizo B, Wijns W, Windecker S, De Belder A

May 19, 2015 | 10.4244/EIJV11I1A6

The need for this supplement: beyond “exercises in style”

Ribichini F, Cuisset T

August 19, 2014 | 10.4244/EIJV10STA1

Percutaneous coronary interventions during ST-segment elevation myocardial infarction: current status and future perspectives

Diletti R, Yetgin T, Manintveld O, Ligthart J, Zivelonghi C, Zijlstra F, Ribichini F

August 19, 2014 | 10.4244/EIJV10STA4

Numbers needed to treat (lives!) and numbers needed to save (money)

Ribichini F, Taggart D, Vassanelli C

June 28, 2013 | 10.4244/EIJV9I2A28

Clinical outcome after endovascular, surgical or hybrid revascularisation in patients with combined carotid and coronary artery disease: the Finalised Research In ENDovascular Strategies Study Group (FRIENDS)

Ribichini F, Tomai F, Reimers B, Russo P, Borioni R, SpartÃ D, Pacchioni A, Pesarini G, Spagnolo B, De Persio G, Cremonesi A, Castriota F

August 15, 2010

The gap between vascular interventions and vascular medicine

Ribichini F, Tomai F, Castriota F, Russo P, Reimers B

May 25, 2010

Long-term results of immunosuppressive oral prednisone after coronary angioplasty in non-diabetic patients with elevated C-reactive protein levels

Ferrero V, Tomai F, Versaci F, Feola M, Proietti I, Rognoni A, Ghini A, Gaspardone A, Vacca G, De Luca L, Vassanelli C, Ribichini F

June 30, 2009

On the current epidemic outburst of meta-analytic rage in interventional cardiology

Agostoni P, Ribichini F, Wijns W

May 19, 2009

Immunosuppressive oral prednisone after percutaneous interventions in patients with multi-vessel coronary artery disease. The IMPRESS-2/MVD study

Ribichini F, Tomai F, Ferrero V, Versaci F, Boccuzzi G, Proietti I, Prati F, Crea F, Vassanelli C

August 20, 2005

Latest news

New issue

EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more

(3D volume-rendered CCTA LAA example)

January 17, 2020

Editorial

From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology”

Robert Byrne

January 17, 2020

JAA

New this week: Inferior caval valve implantation for severe tricuspid regurgitation

January 14, 2020

TRIALS BOOK

Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ...

(The Trials book is supported by Biotronik)

January 15, 2020

Guidance Papers

Guidelines, consensus & position papers

April 9, 2019

Editorial

The role of the Heart Team in the planning of aortic valve replacement

January 15, 2020

JAA

Last week's JAA's: Paravalvular leak after TAVI & TAVI with ACURATE NEO

January 7, 2020

Flavio Ribichini

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke